114 / 1498
Rituximab maintenance vs observation
in relapsed FL (EORTC 20981): PFS
Rituximab maintenance
median 3.7 years
Observation
median 1.3 years
0
1
2
3
4
5
6
7
8
HR = 0.55
p
< 0.0001
Time (years)
0
20
40
60
80
100
PFS increase > 2.4 years
PFS (%)
van Oers MHJ, et al. J Clin Oncol 2010; 28:2853–2858.